Mitochondria-targeted manganese-based mesoporous silica nanoplatforms trigger cGAS-STING activation and sensitize anti PD-L1 therapy in triple-negative breast cancer
DOI:
10.1016/j.actbio.2025.04.040
Publication Date:
2025-04-26T18:50:14Z
AUTHORS (14)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (31)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....